Colorectal Cancer Immunotherapy
Biomarkers for effective treatment for colorectal cancer
While colorectal cancer rates are dropping overall, a worrying trend is emerging: cases are rising in adults between the ages of 20 and 50, who are not screened regularly. Given the necessity of early detection for current treatments, there is a growing need for effective treatments in advanced cases. Immunotherapy for colorectal cancer can be effective, especially in cases where tumors show high microsatellite instability. Join medical oncologist Dr. Luis Diaz Jr. of Memorial Sloan Kettering Cancer Center for a discussion of biomarkers, immunotherapies, and what patients with colorectal cancer need to know. He will be joined by Dr. Andrea Cercek of Memorial Sloan Kettering Cancer Center to answer your questions about genetic and genomic testing, treatment options, and other topics in our live Q&A.
Kidney Cancer Immunotherapy
Lung Cancer Immunotherapy
Pancreatic Cancer Immunotherapy
Prostate Cancer Immunotherapy
Intro to CRI
Cancer Immunotherapy Basics: Harnessing Our Immune System to Fight Cancer
Clinical Trials and Cancer Immunotherapy: Accessing Promising Treatments
Patient Perspectives: Immunotherapy and Clinical Trial Experiences
Bladder Cancer Immunotherapy
Gynecologic Cancer Immunotherapy
Liver Cancer Immunotherapy
Skin Cancer and Melanoma Immunotherapy
Understanding and Overcoming Barriers to Accessing Cancer Care
Blood Cancer Immunotherapy
Breast Cancer Immunotherapy
Go back to event page
Hosts

Tamron Hall
Award-Winning TV Host, Journalist, Executive Producer, and Philanthropist
CRI Experts

Julie Brahmer, MD
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

Andrea Cercek, MD
Memorial Sloan Kettering Cancer Center

Luis Diaz Jr., MD
Memorial Sloan Kettering Cancer Center

Peter E. Fecci, MD, PhD
Duke Cancer Center, DukeHealth, and Duke University

Lawrence Fong, MD
UCSF Helen Diller Family Comprehensive Cancer Center

Matthew D. Galsky, MD
The Tisch Cancer Institute

Sangeeta Goswami, MD, PhD
The University of Texas MD Anderson Cancer Center

Elizabeth Ann Mittendorf, MD, PhD
Dana-Farber/Harvard Cancer Center

Kunle Odunsi, MD, PhD
University of Chicago Medicine Comprehensive Cancer Center

Joseph E. Ravenell, MD
Perlmutter Cancer Center NYU Langone Health

Marcel van den Brink, MD, PhD
Memorial Sloan Kettering Cancer Center

Ana I. Velázquez Mañana, MD MSc
UCSF Helen Diller Family Comprehensive Cancer Center

Robert H. Vonderheide, MD, DPhil
University of Pennsylvania Health System

Jennifer Wargo, MD, MMSc
The University of Texas MD Anderson Cancer Center

Jeffrey S. Weber, MD, PhD
Perlmutter Cancer Center NYU Langone Health

Theodore H. Welling, MD
Perlmutter Cancer Center NYU Langone Health
CRI ImmunoAdvocates

LaToya Bolds-Johnson, PA-C, CAQ-EM
Breast Cancer Advocate & Thriver

Stephen Estrada
Long-term Survivor of Stage 4 Colorectal Cancer

Stephanie Gangi
Breast Cancer Navigator

Sunshine Pegues
Lung Cancer Veteran

John White
Prostate Cancer Veteran
CRI Moderators

Brian Brewer
Cancer Research Institute
Sponsors
Gold
Silver
Contributor
Friend
Host Institutions
Request a clinical trials orientation appointment

Questions?
Contact
[email protected]